These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29569974)

  • 21. Rituximab and ibrutinib in the treatment of Waldenström's macroglobulinemia.
    Grunenberg A; Buske C
    Future Oncol; 2019 Aug; 15(23):2687-2697. PubMed ID: 31184501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MYD88 Mutations and Response to Ibrutinib in Waldenström's Macroglobulinemia.
    Treon SP; Xu L; Hunter Z
    N Engl J Med; 2015 Aug; 373(6):584-6. PubMed ID: 26244327
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement.
    Hiemcke-Jiwa LS; Leguit RJ; Radersma-van Loon JH; Westerweel PE; Rood JJM; Doorduijn JK; Huibers MMH; Minnema MC
    Leuk Lymphoma; 2018 May; 59(5):1256-1259. PubMed ID: 28849690
    [No Abstract]   [Full Text] [Related]  

  • 24. The Impact of Tirabrutinib Monotherapy for Bing-Neel Syndrome in Waldenström's Macroglobulinemia.
    Sekiguchi N
    Intern Med; 2022 Dec; 61(23):3473-3474. PubMed ID: 35569973
    [No Abstract]   [Full Text] [Related]  

  • 25. Ibrutinib for the treatment of Waldenström macroglobulinemia.
    Chakraborty R; Kapoor P; Ansell SM; Gertz MA
    Expert Rev Hematol; 2015 Oct; 8(5):569-79. PubMed ID: 26138997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A head-to-head Phase III study comparing zanubrutinib versus ibrutinib in patients with Waldenström macroglobulinemia.
    Tam CS; LeBlond V; Novotny W; Owen RG; Tedeschi A; Atwal S; Cohen A; Huang J; Buske C
    Future Oncol; 2018 Sep; 14(22):2229-2237. PubMed ID: 29869556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to ibrutinib in a patient with IgG lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation.
    Castillo JJ; Ghobrial IM; Treon SP
    Leuk Lymphoma; 2016 Nov; 57(11):2699-701. PubMed ID: 26980069
    [No Abstract]   [Full Text] [Related]  

  • 28. Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia.
    Castillo JJ; Gustine JN; Meid K; Dubeau T; Severns P; Treon SP
    Haematologica; 2018 Jul; 103(7):e307-e310. PubMed ID: 29472352
    [No Abstract]   [Full Text] [Related]  

  • 29. An Autopsy Case of Bing-Neel Syndrome: Discrepancy between the Radiological and Pathological Findings.
    Matsuda S; Sekiguchi N; Ito K; Takaoka K; Furuki M; Hirano K; Obayashi M
    Intern Med; 2019 Jul; 58(13):1947-1951. PubMed ID: 30918173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO).
    Simon L; Fitsiori A; Lemal R; Dupuis J; Carpentier B; Boudin L; Corby A; Aurran-Schleinitz T; Gastaud L; Talbot A; Leprêtre S; Mahe B; Payet C; Soussain C; Bonnet C; Vincent L; Lissandre S; Herbrecht R; Kremer S; Leblond V; Fornecker LM
    Haematologica; 2015 Dec; 100(12):1587-94. PubMed ID: 26385211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ibrutinib therapy for lymphoplasmacytic lymphoma.
    Helber MJ; Moore JE; Williams AM; Meacham PJ; Rothberg PG; Zent CS
    Am J Hematol; 2017 Sep; 92(9):E542-E544. PubMed ID: 28543765
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia.
    Richardson K; Castillo JJ; Sarosiek SR; Branagan AR; Flynn CA; Meid K; Gustine JN; Liu X; Kofides A; Liu S; Wolf JL; Kacena KA; Patterson CJ; Guerrera ML; Tsakmaklis N; Treon SP; Hunter ZR
    Blood Adv; 2024 May; 8(9):2133-2137. PubMed ID: 38237078
    [No Abstract]   [Full Text] [Related]  

  • 33. Intracranial venous sinus thrombosis as unusual presentation of Bing-Neel syndrome: case illustration.
    Morabito R; Grasso G; Barresi V; La Spina P; Garufi G; Alafaci E; Salpietro FM; Longo M; Granata F; Alafaci C
    J Neurosurg; 2017 Nov; 127(5):1084-1085. PubMed ID: 27911232
    [No Abstract]   [Full Text] [Related]  

  • 34. Ibrutinib discontinuation in Waldenström macroglobulinemia: Etiologies, outcomes, and IgM rebound.
    Gustine JN; Meid K; Dubeau T; Severns P; Hunter ZR; Guang Y; Xu L; Treon SP; Castillo JJ
    Am J Hematol; 2018 Aug; 93(4):511-517. PubMed ID: 29280186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bing-Neel syndrome - Bilateral cavernous sinus lymphoma causing visual failure.
    Pham C; Griffiths JD; Kam A; Hunn MK
    J Clin Neurosci; 2017 Nov; 45():134-135. PubMed ID: 28765059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ibrutinib-induced acute liver failure.
    Kahn A; Horsley-Silva JL; Lam-Himlin DM; Reeder CB; Douglas DD; Carey EJ
    Leuk Lymphoma; 2018 Feb; 59(2):512-514. PubMed ID: 28693376
    [No Abstract]   [Full Text] [Related]  

  • 37. Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia.
    Treon SP; Gustine J; Meid K; Yang G; Xu L; Liu X; Demos M; Kofides A; Tsakmaklis N; Chen JG; Munshi M; Chan G; Dubeau T; Raje N; Yee A; O'Donnell E; Hunter ZR; Castillo JJ
    J Clin Oncol; 2018 Sep; 36(27):2755-2761. PubMed ID: 30044692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained Response of Ibrutinib in a Patient with Waldenstrom Macroglobulinemia Presenting with Myasthenic Crisis as a Paraneoplastic Neurological Syndrome: A Case Report and Review of Literature.
    Lubis AM; Octaviana F; Anindyah G; Harahap AS
    Acta Med Indones; 2024 Apr; 56(2):233-239. PubMed ID: 39010768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrent meningitis revealing a Bing-Neel syndrome].
    Sobczak T; Alleman L; Wille H; Menard F; Benard Y; Perard B; Vareil MO
    Rev Med Interne; 2021 May; 42(5):359-362. PubMed ID: 33663872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bing-Neel syndrome.
    Artemiadis AK; Terentiou A; Kolokythopoulos D; Triantafyllou N; Nikolaou G
    Arq Neuropsiquiatr; 2017 Apr; 75(4):262. PubMed ID: 28489150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.